This study of Asian patients treated for an episode of MDD in actual clinical practice shows that while both duloxetine with a daily dose of ≤60 mg and SSRIs improve depression outcomes and QoL, the effects of duloxetine are likely greater than SSRIs in this popu-lation. Specifically, we found that compared with SSRI-treated patients, duloxetine-treated patients had